Sézary's disease
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Sézary's disease Classification and external resources | |
| ICD-10 | C84.1 |
|---|---|
| ICD-9 | 202.2 |
| ICD-O: | M9701/3 |
| DiseasesDB | 8595 |
| MeSH | D012751 |
|
WikiDoc Resources for Sézary's disease | |
|
Articles | |
|---|---|
|
Most recent articles on Sézary's disease Most cited articles on Sézary's disease | |
|
Media | |
|
Powerpoint slides on Sézary's disease | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Sézary's disease at Clinical Trials.gov Trial results on Sézary's disease Clinical Trials on Sézary's disease at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Sézary's disease NICE Guidance on Sézary's disease
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Sézary's disease Discussion groups on Sézary's disease Patient Handouts on Sézary's disease Directions to Hospitals Treating Sézary's disease Risk calculators and risk factors for Sézary's disease
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Sézary's disease | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Sézary's disease (or "Sézary syndrome") is a type of cutaneous lymphoma characterized by Albert Sézary. [1]
"Sézary's cells" are T-cells that have pathological quantities of mucopolysaccharides.
Sézary's disease is sometimes considered a late stage of mycosis fungoides.
General
Sezary syndrome and Mycosis Fungoides are T-cell lymphomas whose primary manifestation is in the skin.
Etiology
HTLV has thought to have been associated with both of the above cutaneous mycoses.
Symptoms
The hallmark symptoms for Sezary Syndrome are (1) Generalized erythroderma (2)Lymphadenopathy, and (3) Atypical T-cells ("Sezary cells") in the peripheral blood.
Treatment
Vorinostat (Zolinza®) is a second-line drug for CTCL. Treatments are often used in combination.
References
External links
- Illustration of Sezary cells
- Illustration of Sezary cells
- Biography of Sezary (in French)
- Sezary Syndrome lymphoma information
- Doctor's doctor
- Cutaneous Lymphoma Foundation
- [http://www.clinicaltrials.gov/ct/show/NCT00106431 Clinical Trial for Sezary Syndrome
WikiDoc Research Resources for Sézary's disease (Click show to right to view) | |
|---|---|
| Articles on Sézary's disease | Most recent articles on Sézary's disease • Most cited articles on Sézary's disease • Review articles on Sézary's disease • Articles on Sézary's disease in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Sézary's disease | Powerpoint slides on Sézary's disease • Images of Sézary's disease • Photos of Sézary's disease • Podcasts & MP3s on Sézary's disease • Videos on Sézary's disease |
| Evidence Based Medicine Regarding Sézary's disease | Cochrane Collaboration on Sézary's disease • Bandolier on Sézary's disease • TRIP on Sézary's disease |
| Cost Effectiveness of Sézary's disease | Cost Effectiveness of Sézary's disease |
| Clinical Trials Involving Sézary's disease | Ongoing Trials on Sézary's disease at Clinical Trials.gov • Trial results on Sézary's disease • Clinical Trials on Sézary's disease at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Sézary's disease | US National Guidelines Clearinghouse on Sézary's disease • NICE Guidance on Sézary's disease • NHS PRODIGY Guidance • FDA on Sézary's disease • CDC on Sézary's disease |
| Textbook Information on Sézary's disease | Books and Textbook Information on Sézary's disease |
| Pharmacology Resources on Sézary's disease | Dosing of Sézary's disease • Drug interactions with Sézary's disease • Side effects of Sézary's disease • Allergic reactions to Sézary's disease • Overdose information on Sézary's disease • Carcinogenicity information on Sézary's disease • Sézary's disease in pregnancy • Pharmacokinetics of Sézary's disease • |
| Genetics, Pharmacogenomics, and Proteinomics of Sézary's disease | Genetics of Sézary's disease • Pharmacogenomics of Sézary's disease • Proteomics of Sézary's disease |
| Newstories on Sézary's disease | Sézary's disease in the news • Be alerted to news on Sézary's disease • News trends on Sézary's disease |
| Commentary on Sézary's disease | Blogs on Sézary's disease |
| Patient Resources on Sézary's disease | Patient resources on Sézary's disease • Discussion groups on Sézary's disease • Patient Handouts on Sézary's disease • Directions to Hospitals Treating Sézary's disease • Risk calculators and risk factors for Sézary's disease |
| Healthcare Provider Resources on Sézary's disease | Symptoms of Sézary's disease • Causes & Risk Factors for Sézary's disease • Diagnostic studies for Sézary's disease • Treatment of Sézary's disease |
| Continuing Medical Education (CME) Programs on Sézary's disease | CME Programs on Sézary's disease |
| International Resources on Sézary's disease | Sézary's disease en Espanol • Sézary's disease en Francais |
| Business Resources on Sézary's disease | Sézary's disease in the Marketplace • Patents on Sézary's disease |
| Informatics Resources on Sézary's disease | List of terms related to Sézary's disease |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

